SCHEMBL7896107

SCHEMBL7896107

O=c1c2ccccc2c(-c2ccccc2)nn1NC(=S)Nc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.48
▸ ALOX15 P16050 1/20 0.47
▸ HPGD P15428 4/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ LMNA P02545 1/20 0.45
▸ ALDH1A1 P00352 3/20 0.44
▸ TSHR P16473 2/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ PARP1 P09874 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ USP2 O75604 1/20 0.43
▸ TP53 P04637 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7894602 0.82 ALDH1A1 (0.51) MAPTALOX15HPGDSMN1; SMN2LMNA
SCHEMBL7885140 0.77 ALOX15 (0.54) MAPTALOX15HPGDSMN1; SMN2ALDH1A1
SCHEMBL7892210 0.73 ALDH1A1 (0.52) ALOX15HPGDSMN1; SMN2LMNAALDH1A1
SCHEMBL7892188 0.71 ALDH1A1 (0.53) MAPTALOX15HPGDSMN1; SMN2LMNA
SCHEMBL7892197 0.70 LIPG (0.42) MAPTALOX15HPGDALDH1A1MEN1
SCHEMBL1786996 0.69 MEN1 (0.48) MAPTALOX15HPGDSMN1; SMN2LMNA
SCHEMBL1788479 0.69 ALDH1A1 (0.59) MAPTALOX15HPGDLMNAALDH1A1
SCHEMBL1790108 0.69 MAPT (0.56) MAPTALOX15HPGDSMN1; SMN2LMNA
SCHEMBL30795813 0.69 MEN1 (0.48) MAPTALOX15HPGDSMN1; SMN2LMNA
SCHEMBL30794643 0.69 MAPT (0.56) MAPTALOX15HPGDSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6180629-B1 INDUCING OR PROMOTING APOPTOSIS AND FOR ARRESTING UNCONTROLLED NEOPLASTIC CELL PROLIFERATION, INCLUDING PRECANCEROUS AND CANCEROUS LESIONS CELL PATHWAYS, INC. 2001-01-30 — — US disclosed
Send feedback